Intra-aortic balloon counterpulsation in acute myocardial infarction: Old and emerging indications

Netherlands Heart Journal

Volumn 21, Issue 12, 2013, Pages 554-560

  van Nunen, L X ^a,b   van't Veer, M ^a,b   Schampaert, S ^c   Steerneman, B J E M ^a,b   Rutten, M C M ^c   van de Vosse, F N ^c   Pijls, N H J ^a,b  

^a CATHARINA HOSPITAL   (Netherlands)

^b Eindhoven University of Technology ^*  (Netherlands)

^c EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Acute myocardial infarction; Cardiogenic shock; Intra aortic balloon counterpulsation; Persistent ischaemia

Indexed keywords

C REACTIVE PROTEIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; BLOOD PRESSURE; CARDIOGENIC SHOCK; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INFECTION; INTRAAORTIC BALLOON PUMP; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; REPERFUSION; RESUSCITATION; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL;

EID: 84891520492     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/s12471-013-0485-9     Document Type: Article

References (21)

1. Babaev A, Frederick PD, Pasta DJ, et al. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005;294:448-54.
2. Goldberg RJ, Spencer FA, Gore JM, et al. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009;119: 1211-9.
3. Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203:113-8.
4. Kern MJ, Aguirre FV, Tatineni S, et al. Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol. 1993;21:359-68.
5. Prondzinsky R, Unverzagt S, Russ M, et al. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock. 2012;37: 378-84.
6. Sjauw KD, Engstrom AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009;30:459-68.
7. Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287-96.
8. Pierrakos CN, Bonios MJ, Drakos SG, et al. Mechanical assistance by intra-aortic balloon pump counterpulsation during reperfusion increases coronary blood flow and mitigates the no-reflow phenomenon: an experimental study. Artif Organs. 2011;35:867-74.
9. Cheng JM, Valk SD, den Uil CA, et al. Usefulness of intraaortic balloon pump counterpulsation in patients with cardiogenic shock from acute myocardial infarction. Am J Cardiol. 2009;104:327-32.
10. Mehta RH, Harjai KJ, Cox D, et al. Clinical and angiographic correlates and outcomes of suboptimal coronary flow in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol. 2003;42:1739-46.
11. Rezkalla SH, Dharmashankar KC, Abdalrahman IB, et al. Noreflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. J Interv Cardiol. 2010;23:429-36.
12. Anderson RD, Ohman EM, Holmes Jr DR, et al. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I study. Global utilization of streptokinase and TPA for occluded coronary arteries. J Am Coll Cardiol. 1997;30:708-15.
13. Barron HV, Every NR, Parsons LS, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001;141:933-9.
14. Steg PG, James SK, Atar D, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J. 2012;33:2569-619.
15. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004;44:E1-211.
16. Perera D, Lumley M, Pijls NH, et al. Intra-aortic balloon pump trials: questions, answers, and unresolved issues. Circ Cardiovasc Interv. 2013;6:317-21.
17. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation. 2002;105:656-62.
18. Pijls NH, De Bruyne B. Coronary pressure measurement and fractional flow reserve. Heart. 1998;80:539-42.
19. Valk SD, Cheng JM, den Uil CA, et al. Encouraging survival rates in patients with acute myocardial infarction treated with an intra-aortic balloon pump. Neth Heart J. 2011;19:112-8.
20. Patel MR, Smalling RW, Thiele H, et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA. 2011;306:1329-37.
21. Sjauw KD, Engstrom AE, Vis MM, et al. Efficacy and timing of intra-aortic counterpulsation in patients with ST-elevation myocardial infarction complicated by cardiogenic shock. Neth Heart J. 2012;20: 402-9.